Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Multiple Candida Species Detected by Molecular Technique

By LabMedica International staff writers
Posted on 05 Jan 2012
A simplified, specific, and sensitive seminested (PCR) method has been developed to identify medically important Candida species. More...


Novel primer sequences were designed and the seminested PCR was capable of detecting a larger number of Candida species by using annealing temperatures of either 60 °C or 65 °C in the second round of the seminested PCR.

At the Universiti Putra Malaysia (Serdang, Selangor, Malaysia) scientists designed species-specific reverse primers (SSRPs) of 10 Candida species by retrieving at least three internal transcribed spacer (ITS) gene sequences of each species. DNA amplification was performed in a MasterCycler gradient thermocycler. To test the specificity of the method, 27 Candida clinical isolates, 10 Candida American Type Culture Collection (ATCC; Manassas, VA, USA) strains, six Aspergillus ATCC strains, one Cryptococcus neoformans clinical isolate, and one human genomic DNA from an apparently healthy human volunteer were tested.

After optimizing the PCR conditions on the MasterCycler thermocycler (Eppendorf; Hamburg, Germany), the targeted 10 Candida species showed an expected approximate size of PCR amplicons after the second round of PCR with their respective SSRPs. A similar observation was seen when tested on the 27 Candida clinical isolates of various species in the analytical specificity testing. The limit of detection for all Candida species ranged from 0.26 pg to 0.46 pg, except for Candida guilliermondii and Candida kefyr where a 10-fold increase in DNA amount was required.

The authors concluded that the advantages of the high sensitivity feature of seminested PCR were successfully applied, while the drawback usually faced, especially on the limited capability of detecting more species, was overcome. Its usage is favorable in invasive types of fungal infection cases since early rapid detection can be done. This helps to lessen the rate of drug resistance emergence and the precarious use of costly and toxic antifungal drugs for prophylaxis and treatment purposes. The study was published on December 10, 2011, in the journal Diagnostic Microbiology and Infectious Disease.

Related Links:

Universiti Putra Malaysia
American Type Culture Collection
Eppendorf



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Influenza Virus Test
NovaLisa Influenza Virus B IgM ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.